More on SILO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (5/28/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Silo Pharma, Inc. (NQ:SILO)
Delayed: 0.33 -0.02 (5.71%)
Prev. Close $0.35  
Open$0.34 
52 Wk High$ 
52 Wk Low$ 
Day High$0.34 
Day Low$0.31 
P/E N/A  
EPS$ 
Volume138,036 

Friends, Peers and Foes (?): HOTH (more...)

Feb 23, 2026 05:01 PM Form 8-K Silo Pharma, Inc. For: Feb 20
Feb 23, 2026 04:15 PM Silo Pharma authorizes $1 million share buyback program
Feb 23, 2026 04:15 PM Silo Pharma Announces Share Buyback Program
Feb 18, 2026 08:28 AM Silo Pharma receives patent allowance in Japan for PTSD drug SPC-15
Feb 18, 2026 08:28 AM Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio
Feb 17, 2026 10:25 AM Form SCHEDULE 13G/A Silo Pharma, Inc. Filed by: Anson Funds Management LP
Feb 13, 2026 04:49 PM Form SCHEDULE 13G/A Silo Pharma, Inc. Filed by: INTRACOASTAL CAPITAL, LLC
Feb 13, 2026 12:27 PM Form SCHEDULE 13G/A Silo Pharma, Inc. Filed by: SEG Opportunity Fund, LLC
Dec 30, 2025 08:05 AM Silo Pharma signs letter of intent with Allucent for phase 1 studies
Dec 30, 2025 08:05 AM Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15
View All Articles

Entities mentioned with SILO

View All Entities